OHSU

Craig Okada, M.D.

Head Shot of Craig Okada
Email: 
click here
Office: 
503 494-6594

Background

Dr. Okada’s laboratory research is directed towards developing immunotherapy treatments for lymphoma.


Selected Publications

"Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma," Leukemia and Lymphoma (Vol: 52, Issue: 8, Page 1488-1494) - 2011

"A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma," Haematologica Meeting Reports (Vol: 2, Issue: 5, Page 44-45) - 2008

"Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma," Cancer Immunology, Immunotherapy (Vol: 55, Issue: 4, Page 420-432) - 2006

"Gene expression and angiotropism in primary CNS lymphoma," Blood (Vol: 107, Issue: 9, Page 3716-3723) - 2006

"Galloping ophthalmoplegia and numb chin in Burkitt lymphoma," Journal of Neuro-Ophthalmology (Vol: 24, Issue: 2, Page 130-134) - 2004

 

Back to faculty list

OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


Contact

  Email Craig Okada

503 494-6594

Memberships & Associations

American Society of Hematology American Association for the Advancement of Science